Triple-Blind Randomized Clinical Trial of Tocilizumab vs Placebo: Potential Use of an IL-6 Antagonist as an Adjuvant to Standard Treatment for Treatment-Resistant Major Depression in the Brazilian Public Health System (SUS)
Clinical trial NCT07052058 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07052058
- Sponsor
- Hospital de Clinicas de Porto Alegre
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2028-07-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.